<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effect of anesthesia or an <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) glutamatergic <z:chebi fb="68" ids="48706">antagonist</z:chebi> (MK-801) on bladder <z:hpo ids='HP_0000752'>hyperactivity</z:hpo> induced by unilateral middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) occlusion was examined in female rats </plain></SENT>
<SENT sid="1" pm="."><plain>Before infarction, control bladder contractions were monitored in two groups of rats: 1) awake and 2) urethan anesthetized </plain></SENT>
<SENT sid="2" pm="."><plain>The awake rats were then anesthetized with <z:chebi fb="2" ids="5615">halothane</z:chebi>, and <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion was performed in both groups </plain></SENT>
<SENT sid="3" pm="."><plain>After recovery from <z:chebi fb="2" ids="5615">halothane</z:chebi>, bladder capacity in awake rats was significantly reduced (60.8 +/- 1.3%) 0.5-4.5 h after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion but not changed in urethan-anesthetized rats </plain></SENT>
<SENT sid="4" pm="."><plain>MK-801 (0.1 mg/kg i.v.) administered before <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion blocked the reduction in bladder capacity in awake rats 1.5-4.5 h after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion </plain></SENT>
<SENT sid="5" pm="."><plain>Bladder capacity was not changed by sham operation in either the awake or urethan-anesthetized rats </plain></SENT>
<SENT sid="6" pm="."><plain>Urethan administered after recovery from <z:chebi fb="2" ids="5615">halothane</z:chebi> anesthesia increased bladder capacity in <z:chebi fb="70" ids="34342">MCA</z:chebi>-occluded awake rats but not in sham-operated awake rats </plain></SENT>
<SENT sid="7" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> areas in <z:chebi fb="2" ids="5615">halothane</z:chebi>, urethan-anesthetized, or MK-801-treated rats were not significantly different </plain></SENT>
<SENT sid="8" pm="."><plain>These results indicate that <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> induces bladder <z:hpo ids='HP_0000752'>hyperactivity</z:hpo> in awake rats and that urethan or MK-801 inhibits the development of this <z:hpo ids='HP_0000752'>hyperactivity</z:hpo>, most likely by blocking glutamatergic transmission in the brain </plain></SENT>
</text></document>